Zealand Pharma A/S (OCSE:ZEAL) Days Payable : 1,662.51 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Zealand Pharma A/S Days Payable?

Zealand Pharma A/S's average Accounts Payable for the three months ended in Dec. 2023 was kr255.3 Mil. Zealand Pharma A/S's Cost of Goods Sold for the three months ended in Dec. 2023 was kr14.0 Mil. Hence, Zealand Pharma A/S's Days Payable for the three months ended in Dec. 2023 was 1,662.51.

The historical rank and industry rank for Zealand Pharma A/S's Days Payable or its related term are showing as below:

OCSE:ZEAL' s Days Payable Range Over the Past 10 Years
Min: 62.86 Med: 527.83 Max: 39461.34
Current: 3857.95

During the past 13 years, Zealand Pharma A/S's highest Days Payable was 39461.34. The lowest was 62.86. And the median was 527.83.

OCSE:ZEAL's Days Payable is ranked better than
92.16% of 714 companies
in the Biotechnology industry
Industry Median: 146.16 vs OCSE:ZEAL: 3857.95

Zealand Pharma A/S's Days Payable increased from Dec. 2022 (0.00) to Dec. 2023 (1,662.51). It may suggest that Zealand Pharma A/S delayed paying its suppliers.

Zealand Pharma A/S Days Payable Historical Data

The historical data trend for Zealand Pharma A/S's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S Days Payable Chart

Zealand Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

39,461.34

5,602.62

4,270.64

Zealand Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															-	-	-	3,791.56	1,662.51

Competitive Comparison of Zealand Pharma A/S's Days Payable

For the Biotechnology subindustry, Zealand Pharma A/S's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zealand Pharma A/S's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma A/S's Days Payable distribution charts can be found below:

* The bar in red indicates where Zealand Pharma A/S's Days Payable falls into.

Zealand Pharma A/S Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zealand Pharma A/S's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (180.762	+	267.924)	/	2 )	/	19.174	*	365
=	224.343					/	19.174	*	365
=	4,270.64

Zealand Pharma A/S's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (242.652	+	267.924)	/	2 )	/	14.012	*	365 / 4
=	255.288					/	14.012	*	365 / 4
=	1,662.51

Zealand Pharma A/S Days Payable Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zealand Pharma A/S (OCSE:ZEAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OCSE:ZEAL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ZLDPF:USA ZEALc:UK 0NZU:UK 22Z:Germany

Address

Sydmarken 11, Soborg, DNK, DK-2860

Website

https://www.zealandpharma.com

Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.